Human Anti centriole and centrosome antibody IgG ELISA kit
E01A0698-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human IgG antibody Laboratories manufactures the ruxolitinib invivogen reagents distributed by Genprice. The Ruxolitinib Invivogen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Ruxolitinib products are available in stock. Specificity: Ruxolitinib Category: Invivogen

True north Cryobox 15mLBlue
Scientific Laboratory Supplies	PK10	EUR 212.4

True north Cryobox 50mLNatural
Scientific Laboratory Supplies	PK10	EUR 210

True north Cryobox 50mLBlue
Scientific Laboratory Supplies	PK10	EUR 210

True north Cryobox1.5/2mLNatural
Scientific Laboratory Supplies	PK10	EUR 162

True north Cryobox1.5/2.0mLGreen
Scientific Laboratory Supplies	PK10	EUR 162

Human true insulin,TI ELISA Kit
SunredBio	96 tests	EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human true insulin,TI ELISA Kit
ChemNorm	96T	EUR 567.6

Chemicals information

Ruxolitinib (free base)
GW2265-25	Glentham Life Sciences	25	EUR 216.3

Ruxolitinib (free base)
GW2265-5	Glentham Life Sciences	5	EUR 116.1

Ruxolitinib (S enantiomer)
HY-50856A	MedChemExpress	5mg	EUR 408

Ruxolitinib . phosphate salt
10-043	ProSci	25 mg	EUR 387.96
Description: Water-soluble phosphate salt of Ruxolitinib. Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19)

Ruxolitinib . phosphate salt
GW4048-100	Glentham Life Sciences	100	EUR 322.4

Ruxolitinib . phosphate salt
GW4048-25	Glentham Life Sciences	25	EUR 157.3

Ruxolitinib . phosphate salt
GW4048-5	Glentham Life Sciences	5	EUR 92.4

Ruxolitinib (JAK kinase inhibitor)
SIH-509-25MG	Stressmarq	25 mg	EUR 750
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

Ruxolitinib (JAK kinase inhibitor)
SIH-509-5MG	Stressmarq	5 mg	EUR 285.6
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

GFP-lacZ (His) Lentiviral particles, invivo ready
LVP021-PBS	GenTarget	5x107 IFU/ml x 200ul	EUR 1034.4
Description: Pre-made lentiviral particles expressing GFP-LacZ fusion gene with C-term His tag. A RFP was bicistronically expressed under the same suCMV promoter. Concentrated Particles are provided in PBS solution.

S-Ruxolitinib (INCB018424)
A4149-1	ApexBio	1 mg	EUR 277.2
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

S-Ruxolitinib (INCB018424)
A4149-5	ApexBio	5 mg	EUR 514.8
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

S-Ruxolitinib (INCB018424)
A4149-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 367.2
Description: S-Ruxolitinib is the chirality of INCB018424, is a potent and selective small-molecule Janus kinase 1 (JAK1) and JAK2 inhibitor. It was initially developed to target the constitutive activation of the JAK-STAT pathway.

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-10ug
QP9985-iv-10ug	EnQuireBio	10ug	EUR 936

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-50ug
QP9985-iv-50ug	EnQuireBio	50ug	EUR 554.4

ODN 2041-Non-CpG ODN. Invitro control for rabbit cells. Antigen grade
ODN2041-1	Alpha Diagnostics	1 mg	EUR 781.2

Recombinant Mouse TECTB Protein, His, Invitro-E.coli-100ug
QP9985-iv-100ug	EnQuireBio	100ug	EUR 1424.4